CIK 0001299130
- Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161590339
- Phone
- +1 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- 4 Grant or award Chief Financial Officer acquired 6,300 shares (grant or award)
- 4 Open-market sale Director sold 101,666 shares at $50.40 ($5,123,966)
- 4 Open-market sale Director sold 67,500 shares at $48.07 ($3,244,455)
- 4 Open-market sale Director sold 160,000 shares at an average $49.62 ($7,939,764)
- 4 Open-market sale Director sold 125,406 shares at an average $36.34 ($4,556,901)
- 4 Open-market sale Director sold 624,404 shares at an average $37.53 ($23,430,830)
- 4 Grant or award Chief Commercial Officer acquired 160,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 335,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 700,000 shares at an average $24.36 ($17,054,044)
- 4 Open-market sale Director sold 1,492 shares at $14.39 ($21,462)
- 4 Open-market sale Director sold 399,636 shares at an average $15.06 ($6,019,152)
- 4 Open-market sale Director sold 40,582 shares at an average $15.70 ($637,229)
- 4 Open-market sale Director sold 42,488 shares at $15.90 ($675,347)
- 4 Open-market sale Director sold 1,950,000 shares at an average $14.79 ($28,836,800)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 150,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 750,000 shares (grant or award)
Page 9 of 20 · 387 filings